Neurocrine Biosciences Inc. (NBIX) dipped -13.91% or -11.93 to $73.83. It is close to 12.97 million shares traded, which is 1423.26% compare to the average total volume 911584. The market cap of NBIX is $6.70 billion. The year to date change is -5.76%. The 52 week price range is from $64.72 to $126.98. Price of NBIX have changed -0.56% during last week. It have changed -16.74% over last month, -29.61% over last 3 months, -13.51% over last 6 months and 21.49% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBIX is 102.90. It is 39.37% above current price. The 200-day Moving Averages for NBIX is 99.83. It is 35.22% above current price. The 52-week High is 126.98. It is 71.99% from the current price. The 52-week Low is 64.72. It is -12.34% from current price.
There are some statistics of NBIX. It is has market cap $6.70 billion. The share outstanding is 90.68 million. The average volume is 911584. The revenue is 94.52M. The gross profit is 93.76M. The percent of top 15 Institution holding is 169.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBIX is 2.51%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBIX is 1.17%.